TNXP
Tonix Pharmaceuticals Holding Corp. · Healthcare · Market cap $40.8M
Insiders bought $60K net in the last 90 days ·0 sellers, 2 buyers· latest Form 4 filed Nov 12, 2026
Insider Buying
$479K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Nov 12, 2026
LEDERMAN SETH
Tonix Pharmaceuticals Holding Corp. (TNXP) has 9 SEC Form 4 filings (9 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Nov 12, 2026.
Inside the rolling window, 4 insiders at Tonix Pharmaceuticals Holding Corp. reported 8 open-market purchases totaling $479K and no open-market sales. The most active filer is Chief Executive Officer LEDERMAN SETH with 5 filings. Insiders have net bought $193K over the trailing 6 months. The most recent open-market filing is a purchase of 5,000 shares by Chief Executive Officer LEDERMAN SETH, dated Nov 11, 2026, worth $20K.
- Industry:Biotechnology
- CEO:Seth Lederman
- Employees:142
- HQ:Berkeley Heights, NJ, US
- IPO:2012-05-10
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Executive Officer | Purchase | 5,000 | $20K | Nov 12 | -26.5% | SEC ↗ | |
| Chief Executive Officer | Purchase | 2,000 | $28K | Aug 31 | -83.1% | SEC ↗ | |
BAGGER RICHARD HFirst filing | Director | Purchase | 1,000 | $13K | Aug 24 | -80.9% | SEC ↗ |
Taylor Carolyn E.First filing | Director | Purchase | 1,415 | $15K | Jun 15 | -79.3% | SEC ↗ |
Stillwell Richard NewcombFirst filing | Director | Purchase | 5,000 | $58K | Jun 9 | -79.2% | SEC ↗ |
| Chief Executive Officer | Purchase | 5,000 | $59K | Jun 9 | -79.2% | SEC ↗ | |
| Chief Executive Officer | Purchase | 5,000 | $63K | Apr 1 | -82.6% | SEC ↗ | |
LEDERMAN SETHFirst filing | Chief Executive Officer | Purchase | 15,000 | $223K | Mar 18 | -83.2% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does TNXP have?
Tonix Pharmaceuticals Holding Corp. (TNXP) has 9 SEC Form 4 filings (9 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Nov 12, 2026.
When was the most recent SEC Form 4 filing for TNXP?
The most recent Form 4 filing for TNXP on Tracefour is dated Nov 12, 2026.
Who is the most active insider at TNXP?
The most active SEC Form 4 filer at TNXP in the rolling window is Chief Executive Officer LEDERMAN SETH, with 5 filings.
What is the net insider flow at TNXP over the last 6 months?
Over the trailing 180 days, insiders at TNXP have net bought $193K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at TNXP in the current window?
Inside the rolling window, insiders at TNXP bought $479K and sold $0 based on SEC Form 4 filings.
Can I get alerts for TNXP insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Tonix Pharmaceuticals Holding Corp. (TNXP). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Tonix Pharmaceuticals Holding Corp. is in the Healthcare sector.